Charles Feldman to Anti-Bacterial Agents
This is a "connection" page, showing publications Charles Feldman has written about Anti-Bacterial Agents.
Connection Strength
7,487
-
Community-acquired pneumonia: still a major burden of disease. Curr Opin Crit Care. 2016 10; 22(5):477-84.
Score: 0,455
-
Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa. J Infect Dev Ctries. 2016 Apr 28; 10(4):347-53.
Score: 0,442
-
Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012; 2012:584262.
Score: 0,338
-
Antibiotic resistance of pathogens causing community-acquired pneumonia. Semin Respir Crit Care Med. 2012 Jun; 33(3):232-43.
Score: 0,338
-
Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs. 2011 Jan 22; 71(2):131-53.
Score: 0,307
-
Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
Score: 0,290
-
Therapy for pneumococcal bacteremia: monotherapy or combination therapy? Curr Opin Infect Dis. 2009 Apr; 22(2):137-42.
Score: 0,271
-
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother. 2007 Nov; 60(5):1155-8.
Score: 0,243
-
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother. 2007 Feb; 59(2):224-9.
Score: 0,232
-
Controversies in the treatment of pneumococcal community-acquired pneumonia. Future Microbiol. 2006 Oct; 1(3):271-81.
Score: 0,228
-
Vaccines in the fight against antimicrobial resistance - perspectives from South Africa. S Afr Med J. 2024 09 02; 114(9):e2111.
Score: 0,197
-
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Respir Med. 2004 Aug; 98(8):708-20.
Score: 0,196
-
Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004 May; 143(5):269-83.
Score: 0,192
-
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
Score: 0,182
-
A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa. Int J Antimicrob Agents. 2020 Dec; 56(6):106189.
Score: 0,150
-
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel. Chest. 2020 11; 158(5):1912-1918.
Score: 0,149
-
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2020 Aug; 41(4):455-469.
Score: 0,147
-
Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
Score: 0,146
-
Genomic analysis of a multidrug-resistant clinical Providencia rettgeri (PR002) strain with the novel integron ln1483 and an A/C plasmid replicon. Ann N Y Acad Sci. 2020 02; 1462(1):92-103.
Score: 0,140
-
The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism. Int J Immunopharmacol. 1999 Jun; 21(6):365-77.
Score: 0,137
-
The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro. Eur Respir J. 1999 May; 13(5):1022-8.
Score: 0,136
-
Clostridium difficile infection in Johannesburg, South Africa. Hosp Pract (1995). 2018 Dec; 46(5):287-294.
Score: 0,131
-
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia. Respir Med. 2018 07; 140:115-121.
Score: 0,128
-
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. Inflammation. 1997 Dec; 21(6):655-65.
Score: 0,123
-
The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Infect Dis (Lond). 2018 Jan; 50(1):13-20.
Score: 0,120
-
HIV-related pneumococcal disease prevention in adults. Expert Rev Respir Med. 2017 03; 11(3):181-199.
Score: 0,117
-
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation. 1996 Dec; 20(6):693-705.
Score: 0,115
-
Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis. 2016 09; 16(9):1017-1025.
Score: 0,111
-
Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus. Semin Respir Crit Care Med. 2016 Apr; 37(2):214-29.
Score: 0,110
-
Treating patients who have Klebsiella pneumoniae pneumonia. Chest. 1996 Feb; 109(2):587-8.
Score: 0,109
-
Updated recommendations for the management of upper respiratory tract infections in South Africa. S Afr Med J. 2015 Apr 06; 105(5):344-52.
Score: 0,103
-
The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med. 1995 Mar; 89(3):187-92.
Score: 0,102
-
Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother. 2014 Jun; 58(6):3293-305.
Score: 0,096
-
Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol. 2013 Jan; 51(1):369-72.
Score: 0,087
-
The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. S Afr Med J. 2012 May 10; 102(7):599-601.
Score: 0,084
-
Guideline summary: appropriate use of tigecycline. S Afr J Surg. 2012 Feb 14; 50(1):20-1.
Score: 0,083
-
Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints. Surg Infect (Larchmt). 2012 Feb; 13(1):43-9.
Score: 0,082
-
Bronchiectasis: new approaches to diagnosis and management. Clin Chest Med. 2011 Sep; 32(3):535-46.
Score: 0,080
-
Guideline: appropriate use of tigecycline. S Afr Med J. 2010 Jun 01; 100(6 Pt 2):388-94.
Score: 0,073
-
New insights into pneumococcal disease. Respirology. 2009 Mar; 14(2):167-79.
Score: 0,067
-
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. Clin Microbiol Infect. 2007 Feb; 13(2):162-171.
Score: 0,058
-
The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2006 Jul; 10(7):739-43.
Score: 0,056
-
Appropriate use of the carbapenems. S Afr Med J. 2004 Oct; 94(10 Pt 2):857-61.
Score: 0,050
-
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004 Aug 15; 170(4):440-4.
Score: 0,048
-
Guideline for the management of upper respiratory tract infections. S Afr Med J. 2004 Jun; 94(6 Pt 2):475-83.
Score: 0,048
-
Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002; 8 Suppl 2:12-42.
Score: 0,041
-
Prognostic factors in severe community-acquired pneumonia in patients without co-morbid illness. Respirology. 2001 Dec; 6(4):323-30.
Score: 0,041
-
Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis. 2001 Apr; 14(2):173-9.
Score: 0,039
-
Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro. J Antimicrob Chemother. 2000 Aug; 46(2):269-71.
Score: 0,037
-
Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa. Lett Appl Microbiol. 2020 Jan; 70(1):21-28.
Score: 0,035
-
Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. Antimicrob Agents Chemother. 1998 Apr; 42(4):772-8.
Score: 0,032
-
From guidelines to practice: a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2017 04 01; 72(4):1227-1234.
Score: 0,029
-
The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. S Afr Med J. 2016 May 10; 106(6):30-7.
Score: 0,028
-
Community-acquired pneumonia in the ICU. Chest. 1995 Apr; 107(4):1182-3.
Score: 0,026
-
Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005. Pediatr Infect Dis J. 2011 Dec; 30(12):1075-80.
Score: 0,020
-
Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration. 1991; 58(5-6):265-70.
Score: 0,019
-
Klebsiella pneumoniae bacteraemia at an urban general hospital. J Infect. 1990 Jan; 20(1):21-31.
Score: 0,018
-
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis. 2005 Aug 15; 41(4):554-6.
Score: 0,013
-
An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003 Jul 15; 37(2):230-7.
Score: 0,011